Skip to main content
Clinical Trials/EUCTR2015-005017-71-FR
EUCTR2015-005017-71-FRActive, not recruitingPhase 1

Diagnostic value of 18F-choline PET in patients with indeterminate cytology thyroid nodule : A pilot study - CHOCOLATE

Centre François Baclesse0 sites135 target enrollmentStarted: December 3, 2015Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
135

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • - Patient with a thyroid nodule = 15mm with indefinite cytology according to the 2008 Bethesda classification (vesicular lesion of undetermined significance; follicular neoplasm or cell Hürthle; lesion suspicious for malignancy), and to be operated
  • - Age = 18 years
  • - Patient affiliated to a social security scheme
  • - Informed consent and signed
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 135
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 135

Exclusion Criteria

  • - Thyroid nodule <15mm
  • - Coalescing nodules preventing a correct individualization of the target nodule;
  • - Nodules with no indeterminate cytology , ie nondiagnostic cytology, benign and malignant cytology
  • - Major subject of a legal protection measure or unable to consent
  • - Refusal to participate

Investigators

Sponsor
Centre François Baclesse

Similar Trials